Overall rank by patents
#8,380
Across all tracked assignees
USPTO PatentsView assignee record - 38 granted patents across 24 technology areas, active 2015–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,).
The verdict
Express holds 38 US patents across 24 technology areas, rank #8,380 of 50,000 tracked assignees.
Express Scripts, Inc. has been granted 38 US utility patents between 2015 and 2017, placing Express Scripts, Inc. at rank #8,380 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.3 claims per patent with primary concentration in G06Q (INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE,). As a US Corporation, Express Scripts, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Express sits between Elkem Silicones France SAS (38 patents, rank #8,376) and Frazier Industrial Company (38 patents, rank #8,384) - the closest US assignees by grant volume. The composite Innovation Score of 36.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 38 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Express Scripts, Inc.'s 10.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Express Scripts, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elkem Silicones France SAS
38 patents
Emirates Telecommunications Corporation
38 patents
Endocyte, Inc.
38 patents
Excelitas Technologies Corp.
38 patents
FAR EASTERN NEW CENTURY CORPORATION
38 patents
FIBERLEAN TECHNOLOGIES LIMITED
38 patents
FLEXIV LTD.
38 patents
FRAZIER INDUSTRIAL COMPANY
38 patents
Express Scripts, Inc.
38 patents
What this shows Express holds 38 patents at rank #8,380, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,380 in granted patent volume.
Other assignees with the most granted patents in Express's primary technology class.
Express's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 15.8% |
| 2016 | 12 | 31.6% |
| 2017 | 20 | 52.6% |
Top 15 of 24 technology areas
Overall rank by patents
#8,380
Across all tracked assignees
36.2 out of 100
How to use this portfolio
Express's 38 grants land it in the top 47% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.